Evidence map›Paper›PMID 41266031›Full record

ArticleMethods in enzymology2025

Parameterizing non-canonical amino acids for cyclic peptide simulations.

N Kithmini Wijesiri, Benjamin P Brown

Abstract read
In one paragraph

Article in Methods in enzymology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

N Kithmini WijesiriDepartment of Pharmacology, Center for AI in Protein Dynamics, Vanderbilt University, Nashville, TN, United States.
Benjamin P BrownDepartment of Pharmacology, Center for AI in Protein Dynamics, Vanderbilt University, Nashville, TN, United States. Electronic address: benjamin.p.brown@vanderbilt.edu.

Funding

Developing a computational platform for induced-fit and chemogenetic drug designDP1DA058349 · NIDA · VANDERBILT UNIVERSITY · PI Benjamin Patrick Brown · 2023 to 2026
$1.9M
NIDA NIH HHS DP1 DA058349
6 · The paper itself

Abstract

Non-canonical amino acids (ncAAs) are increasingly used to expand the functional chemical space available to biomolecular design. They are particularly useful for cyclic peptides, which have smaller interaction surfaces than proteins and thus require precisely tuned high-affinity contacts with very specific chemical motifs to achieve target affinity and selectivity. Despite rapid advances in machine learning for biomolecular modeling and design, physics-driven approaches remain the predominant choice for exotic chemistries because they pair generalizable, classically defined energy functions/force fields with scalable performance. High-quality, transferable parameters exist for the 20 canonical amino acids, but not for the far larger space of ncAAs; as a result, practitioners are often required to create their own residue definitions before meaningful scoring, sampling, or molecular dynamics (MD) simulations are possible. Doing so is challenging because it is a multi-step process requires careful attention to ensure compatibility of the residue definition for the target modeling tools (e.g., Rosetta and AMBER). Here we provide a guide for building custom ncAAs for biomolecular modeling and design in Rosetta and MD simulation in AMBER. Our guide is presented specifically in the context of cyclic peptide modeling. We provide sample scripts for each major step of the protocol and include validation checkpoints and representative outputs. Together, we anticipate that these resources will enable novices and experts alike to efficiently generate robust ncAA parameters for Rosetta-based modeling/design and AMBER MD simulations.

Indexed as

Amino AcidsMolecular Dynamics SimulationPeptides, CyclicSoftwareAmino AcidsPeptides, CyclicAMBERCyclic peptidesMolecular dynamicsNon-canonical amino acidsParameterizationRosettaUnnatural amino acids

Identifiers

PMID41266031
PMCPMC12713365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.